Section 1 Short title
This Act may be cited as the “Empowering Pharmacists in the Fight Against Opioid Abuse Act”.
Empowering Pharmacists in the Fight Against Opioid Abuse Act
A BILL
To provide for the development and dissemination of programs and materials for training pharmacists, health care providers, and patients on the circumstances under which a pharmacist may decline to fill a prescription for a controlled substance because the pharmacist suspects the prescription is fraudulent, forged, or otherwise indicative of abuse or diversion, and for other purposes.
Sec. 2 Programs and materials for training on certain circumstances under which a pharmacist may decline to fill a prescription
In general— Not later than 1 year after the date of enactment of this Act, the Administrator of the Drug Enforcement Administration, in consultation with the Secretary of Health and Human Services and the Commissioner of Food and Drugs, shall develop and disseminate programs and materials for training pharmacists, health care providers, and patients on—
circumstances under which a pharmacist may, consistent with section 201 of the Controlled Substances Act (21 U.S.C. 801 et seq.) and regulations thereunder, including section 1306.04 of title 21, Code of Federal Regulations, decline to fill a prescription for a controlled substance because the pharmacist suspects the prescription is fraudulent, forged, or otherwise indicative of abuse or diversion; and
any Federal requirements pertaining to declining to fill a prescription under such circumstances.
Stakeholder input— In developing the programs and materials required by paragraph (1), the Administrator of the Drug Enforcement Administration shall seek input from relevant national, State, and local associations, boards of pharmacy, medical societies, and licensing boards.